clinical trial · NCT02140047
Exploratory Clinical Study of MT-2301
Haemophilus Influenza Type bHaemophilus b conjugate vaccine diphteria CRM197 protein conjugate)-Low + DPT-IPVHaemophilus b conjugate vaccine diphteria CRM197 protein conjugate)-High + DPT-IPVHaemophilus influenza type b conjugate vaccine + DPT-IPV
brief summary
The purpose of this study is to evaluate efficacy and safety of MT-2301 when co-administered with DPT-IPV using ActHIB® as a control in healthy infants.
started
Apr 1, 2014
primary completion
Jan 1, 2015
completion
Sep 1, 2015
last updated
Mar 17, 2026
official title
Exploratory Clinical Study of MT-2301 in Healthy Infants (Phase 2)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol